Stanca A Birlea
Stanca A Birlea
Prospective Evidence on Artificial Intelligence-Assisted Melanoma Diagnostics: A Systematic Review and Meta-Analysis [0.03%]
基于人工智诊断黑色素瘤的前瞻性证据：系统评价和meta分析
Sara Laiouar-Pedari,Arlene Kühn,Christoph Wies et al.
Sara Laiouar-Pedari et al.
Importance: Dermoscopy is a standard of care for melanoma diagnostics, and artificial intelligence (AI) systems are increasingly investigated as decision-support tools. Prospective evidence is essential to assess their pe...
Successful Treatment of Acquired Idiopathic Generalized Anhidrosis With Baricitinib [0.03%]
巴瑞克替尼治疗获得性特发性全身无汗症有效
Yi-Han Chang,Julia Yu-Yun Lee,John A McGrath et al.
Yi-Han Chang et al.
Appointment Access and Waiting Times in General and Pediatric Dermatology [0.03%]
皮肤病和儿科皮肤病的预约权及等待时间
Elizabeth Garcia-Creighton,Nicholas A Felan,Jasmine V Hartman Budnik et al.
Elizabeth Garcia-Creighton et al.
Kanade Shinkai
Kanade Shinkai
Felipe Peirano,Virginia Llanos,Ashfaq A Marghoob
Felipe Peirano
Intralesional Interleukin-2 Therapy for Treatment of Cutaneous Squamous Cell Carcinoma [0.03%]
治疗皮肤鳞状细胞癌的瘤内注射白介素-2疗法
Carman Anthony Giacomantonio,Dejan Vidovic,Brianne Cruickshank
Carman Anthony Giacomantonio
Importance: Cutaneous squamous cell carcinoma (cSCC) remains one of the most common cancers affecting the general population. It is generally cleared surgically, yet it is challenging to manage recurrent disease, locally ...
A Pigment-Informed Dermatology Framework-Reimagining "Skin of Color" [0.03%]
一种 pigment-informed皮肤病学框架——重新构想“有色皮肤”
Rashmi Sarkar,Hitaishi Mehta
Rashmi Sarkar
Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial [0.03%]
复发性难治性汗腺炎患者接受Lutikizumab治疗的2期随机临床试验
Alexa B Kimball,Konrad T Sawicki,Lindsay Ackerman et al.
Alexa B Kimball et al.
Importance: Hidradenitis suppurativa (HS) is a debilitating inflammatory skin disease with limited therapeutic options. Objective: To a...
Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance Trial [0.03%]
黑色素瘤自我监测试验筛查和随机分组患者的特征
Ellie Medcalf,Deonna M Ackermann,Jake T W Williams et al.
Ellie Medcalf et al.
Importance: The MEL-SELF randomized clinical trial (RCT) evaluated patient-led surveillance as an alternative model of follow-up. The baseline characteristics of participants provide insights into current unmet clinical n...